Background: This study summarizes our experience in the surgical management of arterial lesions secondary to Behçet disease (BD) and assesses the value of endografts.
Behçet disease (BD) is a rare multisystem inflammatory condition characterized by a wide clinical spectrum, including recurrent oral and genital ulcers, skin lesions, ocular inflammation, systemic vasculitis, and neurologic, renal, and gastrointestinal involvement. 1 The prevalence of BD varies worldwide, with the highest prevalence being 0.1% in parts of the Middle East. 2 Arterial involvement is found in w2.2% to 18% of patients, 3, 4 two-thirds with aneurysms and one-third with stenotic or occlusive lesions. 5, 6 Arterial lesions are usually health-threatening, with the rupture of an arterial aneurysm being the leading cause of death in BD patients. 7, 8 Therapeutic management of BD often involves the use of immunosuppressive drugs to suppress inflammation and prevent irreversible damage to affected tissues. 9 Because arterial lesions in BD rarely regress using only immunosuppressive therapy, surgical interventions are necessary. However, the long-term surgical outcomes are greatly impaired by a high rate of postoperative complications, generally attributed to defects of the artery wall and surrounding inflammation. 6, 10 Nevertheless, most authors concur that immunosuppressive therapy should be administered preoperatively and postoperatively and that operations should be avoided for as long as possible after complete disease remission. [11] [12] [13] Apart from the intrinsic pathophysiologic changes of BD, vascular graft selection is another key factor influencing the success of surgical outcomes. [14] [15] [16] [17] Autologous great saphenous vein (GSV) and synthetic graft interpositions and bypasses have been used as standard methods for many years, with successful outcomes in most cases. [18] [19] [20] [21] [22] Despite the initial success, long-term outcomes have been greatly impaired due to a considerable number of postoperative anastomotic pseudoaneurysms and graft occlusions, with the reported occurrence rates of 12.9% to 50% and 8.3% to 38%, respectively. [23] [24] [25] [26] [27] [28] Whether GSV or synthetic grafts should be chosen in the first instance is controversial. Some authors questioned the reliability of GSV grafts. Kalko et al 24 and
Berard et al 29 reported that they used only synthetic grafts because of the concern that GSV grafts might lead to vasculitis. Others argued that the choice of GSV or synthetic graft did not influence complication rates.
In a recent report by Koksoy et al, 22 polytetrafluoroethylene (PTFE) and GSV grafts were both used for treating peripheral artery aneurysms resulting from BD. The total incidence of anastomotic pseudoaneurysm and graft occlusion was 24% and 38%, respectively, comparable the 20% and 40%, respectively, reported by Tuzun et al, 30 who used only synthetic graft. Autologous GSV grafts appear to offer superior flexibility and histocompatibility compared with synthetic grafts. This characteristic is favorable for the maintenance of graft patency and decreasing tension at the anastomotic sites, especially in lesions near the joints such as the popliteal arteries.
In the past decade, endovascular interventions have brought with them the major advantage of being minimally invasive and essentially free of suture line trauma, especially in the management of thoracic and abdominal aortic arterial aneurysms. Several groups have reported a considerably low rate of pseudoaneurysms and a high patency rate, 16, [30] [31] [32] [33] [34] and therefore, this comparatively new approach has been considered an ideal alternative to open surgery. However, there has been no evidence to date to indicate that endografts are superior to conventional grafts for arterial BD lesions of different types (eg, aneurysm, occlusion, and stenosis).
To address this, we studied BD patients who underwent surgery for arterial lesions in our center and compared the outcomes of using different types of vascular grafts.
METHODS
The First Affiliated Hospital of Sun Yat-sen University Institutional Review Board approved the experimental protocol. Informed consent for the study was not required.
Patients and diagnosis. This was a retrospective clinical research study. Data from BD patients with arterial lesions who were surgically managed in the First Affiliated Hospital of Sun Yat-sen University (Guangzhou, China) from January 1998 to December 2015 were analyzed. BD was diagnosed according to the criteria of International Study Group for Behçet's Disease. 1, 35 A positive diagnosis must fulfill one required criteria: recurrent oral ulcerations: minor aphthous, major aphthous, or herpetiform ulceration observed by physician or patient, which recurred at least three times in a 12-month period, and at least two of the following minor criteria: recurrent genital ulceration, eye lesion, skin lesions, or positive pathergy test. 36 Other causes of large-vessel abnormalities, such as Kawasaki disease, Takayasu disease, tuberculosis, syphilis and Marfan syndrome, were excluded on the basis of clinical symptoms, serologic testing, imaging findings, and histologic inspections. Inclusion of patients with recent or remote trauma and drug abuse was restricted.
Arterial lesions were diagnosed by color duplex ultrasound imaging, followed by enhanced computed tomography (CT). Serologic examinations were used to assess the disease status of all patients. Elevated erythrocyte sedimentation rate, C-reactive protein, or leucocyte counts were considered as evidence of active disease.
Immunosuppressive therapy. Immunosuppressive therapy plans were made according to the European League Against Rheumatism recommendations for management of BD 12 and overseen by rheumatologists in our center.
For patients who were diagnosed to be in complete disease remission when admitted, prednisone was prescribed at a dosage of 0.5 mg/kg daily before surgery, and this was gradually reduced to 5 to 10 mg daily by the end of the 6 months after surgery and continued for a further 2 years.
For patients with active disease but no evidence of fever, ulcers in the mouth or on the genitals, arthritis, nodular erythema, folliculitis-like lesions, or inflammation of the digestive tract, prednisone was prescribed at a dosage of 1 mg/kg daily, together with intravenous cyclophosphamide (200 mg every other day) until the disease-determining parameters decreased to a normal level. Cyclophosphamide was tapered to 50 mg daily postoperatively and withdrawn 1 month later. The dosage of prednisone gradually reduced to 0.5 mg/kg daily at the end of 3 months and to 5 to 10 mg/d at the end of 6 months and maintained for at least 2 years.
In patients with active disease and manifesting aneurysm rupture and acute tissue ischemia, intravenous hydrocortisone (200 mg/d) and cyclophosphamide (200 mg/d) were prescribed before the surgery and were given for an additional 3 to 7 days after surgery. The prescriptions were then converted to oral prednisone (1 mg/kg daily) combined with cyclophosphamide (200 mg every other day). When complete remission was achieved, cyclophosphamide was withdrawn, and prednisone was gradually reduced to 5 to 10 mg/d and continued for at least 2 years.
Surgical strategies and graft selection. As far as possible, surgical procedures were scheduled for when patients had achieved complete remission after strict immunosuppressive therapy. Emergency interventions were only performed for ruptured aneurysms and acute tissue ischemia.
CT and ultrasound examinations were performed preoperatively to evaluate the status of the proximal and distal artery segments in detail and to determine the anastomotic sites of inflow and outflow tracts. Bilateral GSVs were also checked by ultrasound imaging to exclude the potential involvement of vasculitis and assess whether they might be used as autologous grafts. All of these factors were taken into consideration to determine the most appropriate surgical method, graft type, and proximal or distal anastomotic site. In general, open GSV bypass or interposition was chosen as the first-line treatment for lesions near the joint and for arteries with a diameter of <5 mm. Endograft implantation was preferred for lesions of aortic and visceral arteries. Synthetic grafting was only performed when anatomic features were unfavorable for endograft implantation or GSV was unavailable. In all patients, except for those undergoing autologous GSV grafting, a second-generation cephalosporin was administered before surgery.
Follow-up. The patients were assessed at 3-month intervals in the first year and yearly thereafter. Symptom assessment, physical examination, serologic testing and color duplex Doppler ultrasound imaging were done at each appointment to assess disease and graft status, respectively. Enhanced CT was used only for patients with abnormal results on the ultrasound examination. Immunosuppressants and antiplatelet agents were adjusted according to these findings and the advice from the patients' rheumatologists. Major graft-related complications, including anastomotic pseudoaneurysms, graft occlusions, and graft infections, were recorded and managed appropriately.
Statistical analysis. Continuous data are presented as mean 6 standard deviation. Categoric data are indicated with a number and percentage. As a result of the small sample size, the primary study outcome was a composite end point of anastomotic pseudoaneurysm, occlusion or stenosis (>60%), graft infection, or artery rupture. The Kaplan-Meier method was used to calculate the complication-free survival rates, and the survival distribution of the three groups was compared with a logrank test. The Fisher exact test was used to explore the association between retreatment and the primary surgical modality. Statistical analyses were performed using IBM SPSS 20 software (IBM Corp, Armonk NY). Statistical significance was defined as P < .05.
RESULTS
Altogether, 41 patients with arterial lesions secondary to BD were managed surgically in our center between January 1998 and December 2015. After the exclusion of eight patients for whom follow-up data were unavailable, 33 patients (29 men and 4 women; 7.25:1 male-tofemale ratio) were recruited. Patients were an average age of 36.7 years (range, 25-51 years). The frequencies of different symptoms are given in Table I . Elevated values for erythrocyte sedimentation rate, C-reactive protein, or leukocyte counts were noted in 17 patients (51.5%) at admission.
Preoperative enhanced CT revealed 27 aneurysms in 24 patients (72.7%), and nine stenotic/occlusive lesions in nine patients (27.3%). The most frequently involved vessel was the femoral artery (27.8%), followed by the aorta (19.4%), popliteal (13.9%), superior mesenteric artery (SMA; 11.1%), iliac (8.3%), subclavian (8.3%), renal (5.6%), and carotid arteries (5.6%; Table II The three types of vascular grafts were used for repairing arterial lesions at various anatomical locations, determined by the availability of autologous GSV grafts and the nature of the lesion. Autologous GSVs were not used for repairing large-diameter arteries, such as the thoracic and abdominal aorta, whereas synthetic grafts were considered appropriate for a wide range of arterial lesion sites. Endografts were used also for largediameter and for medium-to small-diameter arterial lesions such as the aorta, common iliac artery, and the subclavian artery. One patient with a thoracoabdominal aneurysm received staged hybrid procedures. Retrograde synthetic graft bypasses from bilateral common iliac arteries to visceral arteries were established first to restore perfusion of the visceral branches, followed by endovascular covered stent implantation 7 days later to isolate the aneurysm.
All primary procedures were successful, with a technical success rate of 100%. The average postoperative hospital stay was 8.5 days (range, 2-14 days). No in-hospital severe complications or deaths occurred during this session.
Major complications in different kinds of grafts. During the follow-up time of 3.8 6 2.9 years, pseudoaneurysms were observed in three GSVs (20%) and in three synthetic grafts (38%), all at the anastomotic sites, whereas endograft implantations did not result in pseudoaneurysms. Graft occlusion or stenosis was seen in 1 GSV (7%), 2 synthetic grafts (25%), and 2 endografts (15%). Graft infection occurred in one synthetic graft (13%) and in one endograft (8%). Artery rupture occurred only in one endograft (8%; Table III ). The results of log-rank test showed the overall probability of a complication does not significantly differ among the three types of graft (P ¼ .713; Table III ). The Fig shows the complication-free survival rates in patients with different kinds of grafts examined by the Kaplan-Meier method with log-rank analysis.
Graft-related complications and retreatment procedures. At the first-time retreatment, 4 patients received covered stent implantations (an Endurant cuff in 1 patient, Viabahn in 2, and Fluency in 1), 1 for an anastomotic pseudoaneurysm after GSV interposition of a popliteal artery aneurysm, 2 for anastomotic pseudoaneurysms after synthetic graft interposition of an abdominal aortic aneurysm and an aortic occlusion, and 1 for rupture of the distal anchored artery after endovascular repair of an abdominal aortic aneurysm. Two patients with anastomotic pseudoaneurysms after GSV interpositions of femoral artery aneurysms were retreated with PTFE synthetic graft bypasses. One patient with renal artery stent stenosis was retreated with balloon dilation.
Acute graft occlusion and lower limb gangrene developed in two patients: one had been given an endograft implantation for a popliteal artery aneurysm and the other a GSV interposition for a femoral artery aneurysm. Both patients underwent above-knee amputation. Skin ulcer along with graft infection and occlusion developed in another patient 3 years after receiving a synthetic graft bypass of the bilateral common carotid arteries. The occluded and infected graft was removed, and no cerebral ischemia occurred. One patient accepted graft removal and PTFE femoral-femoral bypass for graft infection 5 months after endovascular repair of an iliac artery aneurysm.
Anastomotic pseudoaneurysm recurred in one patient who had received a synthetic graft bypass for anastomotic pseudoaneurysm after initial GSV interposition for a femoral artery aneurysm. The artery was ligated, and no limb gangrene developed. Altogether, 12 patients required retreatment. The results of the Fisher exact test indicate that retreatment is not associated with the primary surgical modality (P ¼ .775).
Mortality. Two patients died before retreatment, giving a mortality rate of 6.1%. One died of acute stent occlusion and extensive small intestine gangrene 1 month after a covered stent implantation for a ruptured SMA aneurysm. The second died of the sudden rupture of a pseudoaneurysm at the proximal anastomosis 18 months after the primary synthetic graft interposition for iliac artery aneurysm.
DISCUSSION
In this retrospective study, we compared the surgical outcomes among three types of vascular grafts used for repairing arterial lesions secondary to BD. The type of vascular graft was determined from preoperative assessment according to the availability of GSV grafts and the nature of the lesion to be repaired. From our data set, it was apparent that GSV grafts were preferred for repairing arteries with a small to medium diameter, whereas synthetic grafts and endografts were used for a wider range of artery types.
GSV grafts have been reported to be ideal for repairing arterial lesions in arteries of small to medium diameter (6-8 mm), such as the carotid and common femoral arteries. 37 GSV grafts are generally not considered for use on aortic lesions mainly because of the mismatch in arterial diameter. Of the 15 GSV grafts used for repairing medium-diameter arteries (including SMA, femoral, and popliteal arteries), there were only three anastomotic pseudoaneurysms (20%) and one occlusion (7%). This is lower than that of synthetic grafts, although no statistically significant difference was confirmed. Furthermore, none of the GSV grafts developed vasculitis despite previous literature suggesting that GSV grafts are linked with vasculitis. 24, 29 We adopted an endovascular intervention for different artery lesions in our patients. Because we did not observe any anastomotic pseudoaneurysms after the 13 endografts used, we conclude that endografts are superior to GSV and synthetic grafts with respect to avoiding anastomotic trauma. From our data, we noticed that endograft stenoses or occlusions did not occur when they were implanted in the aortic or iliac arteries but were more frequently seen in arteries near the joints (eg, the popliteal arteries).
The relatively high rate of complications for endografts used within the femoral and popliteal arteries may be attributed to their exposure to chronic outward force created by the endografts and the constant mechanical forces as a result of muscle contraction and joint movement. Subsequent intimal proliferation further reduces the patency of these small-diameter arteries. Nevertheless, endograft implantations of arteries that are protected within the body cavity, such as the SMA and the renal artery, were also suboptimal even though they are not subjected to external or internal mechanical forces. This phenomenon may be explained by the chronic stress exerted by the endograft to the arterial walls and the possibility of endothelial hyperproliferation, which increases the risk of stenosis and occlusion. In addition, the endografts used may have a slow rate of re-endothelization that may be inadequate for the maintenance of optimal graft patency. Therefore, to achieve long-term success of endograft implantation, the next-generation endograft must possess a high level of flexibility, stress resistance, antithrombotic ability, and histocompatibility. Unfortunately, current endografts do not satisfy these requirements. 8, 38 An unusual complication occurred after endograft implantation in one of our earlier patients. The left common iliac artery close to the distal end of endograft ruptured, without any prior warning, 1 month after endovascular management of an abdominal aortic aneurysm. There were no interpretations reported regarding the cause of this, but we suspect that it was likely due to chronic injury to the artery wall caused by the rigid ends of oversized endografts. This type of injury has been noted previously. For example, Kwon et al 39 reported a series of 12 BD patients with abdominal aortic aneurysms. Of the six endografts implanted, pseudoaneurysms occurred in two, proximal or distal to the ends of endografts. 39 As a result of this experience, seriously tortuous lesions were excluded from endovascular management in our patient cohort. Furthermore, when endovascular procedures were considered, endografts with higher flexibility and <5% oversize compliance were recommended. Subsequently, no similar complications were observed. The poor resistance of artificial materials to bacterial infection is another drawback of endografts. In our cohort, one patient with an endograft infection had to undergo a second surgical procedure and needed long-term treatment with antibiotics. The patient survived, but at the detriment of an additional surgical intervention causing trauma to the body and considerable financial cost.
Regardless of the type of graft used, for open surgery, key surgical skills proved useful in reducing arterial trauma. Preoperative and intraoperative inspection of the aimed inflow and outflow segment is particularly important, and the use of the normal arterial segments during the operation is recommended. 24 In addition, keeping the graft in a relaxed position avoids stretching the suture line and minimizes injury to the artery wall. By contrast, endografts confer an important advantage because they do not involve an incision or anastomosis of the arteries. Because BD is an extremely rare condition and only up to 18% patients may develop arterial lesions and require surgical intervention, gathering enough patients to study this condition effectively is challenging. Although our sample size was small and our patients were heterogeneous, we achieved a reasonable sample size compared with some of the previously published studies of BD. 14, 20, 24 Although controlling for variations attributed to some internal and external factors was not possible, we were able to maximize the consistency on intervention strategies. Nonetheless, further studies involving larger cohorts with long-term follow-up may be needed to study in depth the role of endograft in the management of arterial lesions in BD patients.
CONCLUSIONS
We have performed a study comparing three kinds of vascular grafts. The complication rates were in line with those reported previously. [21] [22] [23] 27, 28 Our results confirm the enhanced performance of endografts in avoiding anastomotic pseudoaneurysms. However, the incidence of occlusion in the femoral and popliteal arteries is higher with endografts. Another drawback of endografting concerns its anti-infective properties. We conclude from our findings that although endografts are an attractive treatment option, improvements in patency and bacterial resistance must be made before they can replace fully GSV and synthetic grafts for the treatment of arterial lesions in BD. 
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